Turnstone Biologics Corp.
TSBXDelisted Aug 11, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764974
Turnstone Biologics Corp. was delisted on Aug 11, 2025; its insiders filed their last Form 4 on Aug 12, 2025; 23 institutions reported holding it in 13F filings for Q2 2025, worth $3.03M in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Turnstone Biologics Corp. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +4 vs. Q3 2024
- Shares held
- 11.1M
- −346.6K (−3.0%) vs. Q3 2024
- Total value
- $5.51M
- −$864.2K (−13.6%) vs. Q3 2024
- New holders
- 7
- 6 more added
- Sold out
- 3
- 6 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TSBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 23 | $3.03M |
| Q1 2025 | 23 | $4.26M |
| Q4 2024 | 28 | $5.51M |
| Q3 2024 | 24 | $6.37M |
| Q2 2024 | 47 | $33.3M |
| Q1 2024 | 40 | $35.0M |
| Q4 2023 | 36 | $33.1M |
| Q3 2023 | 35 | $48.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Turnstone Biologics Corp.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 71 | $35 | 0.00% | −10,572−99.3% | Reduced |
| JPMorgan Chase & Co | 199 | $98 | 0.00% | +41+25.9% | Added |
| Morgan Stanley | 4,701 | $2.34K | 0.00% | −1,300−21.7% | Reduced |
| Tower Research Capital LLC (TRC) | 4,806 | $2.39K | 0.00% | −170−3.4% | Reduced |
| XTX Topco Ltd | 11,759 | $5.82K | 0.00% | +11,759 | New |
| Acadian Asset Management LLC | 17,833 | $7.00K | 0.00% | −18,621−51.1% | Reduced |
| Virtu Financial LLC | 14,810 | $7.00K | 0.00% | +14,810 | New |
| BNP Paribas Arbitrage, SA | 15,238 | $7.57K | 0.00% | +15,238 | New |
| Northern Trust Corp | 18,405 | $9.14K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 20,518 | $10.2K | 0.00% | +20,518 | New |
| Renaissance Technologies LLC | 23,900 | $11.9K | 0.00% | +23,900 | New |
| BlackRock, Inc. | 43,192 | $21.5K | 0.00% | +264+0.6% | Added |
| Citigroup Inc | 61,413 | $30.4K | 0.00% | +61,413 | New |
| Susquehanna International Group, LLP | 67,324 | $33.3K | 0.00% | +67,324 | New |
| Millennium Management LLC | 73,744 | $36.5K | 0.00% | −29,284−28.4% | Reduced |
| Barclays PLC | 114,058 | $56.7K | 0.00% | +4,014+3.6% | Added |
| Geode Capital Management, LLC | 138,659 | $68.6K | 0.00% | +5,840+4.4% | Added |
| FIL Ltd | 192,657 | $95.4K | 0.00% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 517,648 | $257.2K | 0.17% | 00.0% | Unchanged |
| 72 Investment Holdings, LLC | 549,980 | $273.3K | 0.56% | 00.0% | Unchanged |
| Vanguard Group Inc | 578,995 | $286.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 689,213 | $342.5K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 891,526 | $442.2K | 0.00% | −20,215−2.2% | Reduced |
| Takeda Pharmaceutical Co Ltd | 895,824 | $447.9K | 1.69% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 932,348 | $463.3K | 0.04% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 934,364 | $464.3K | 0.00% | +2,138+0.2% | Added |
| FMR LLC | 1,184,043 | $586.1K | 0.00% | +11,056+0.9% | Added |
| OrbiMed Advisors LLC | 3,099,265 | $1.54M | 0.03% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −454,026−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −49,880−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −800−100.0% | Sold out |